Developing a new non-hormonal treatment for endometriosis
Novel, Non-hormonal Therapeutic for Endometriosis
This study is testing a new treatment called ENDO-205 for endometriosis, which aims to help women by targeting the disease directly without the side effects of current options, making it a promising step towards better health for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Endomet Biosciences, INC NIH-funded |
| Lab location | 1 site (Irvine, UNITED STATES) |
| Project ID | NIH-11186444 on NIH RePORTER |
What this research studies
This research aims to create the first disease-modifying and non-hormonal therapy for endometriosis, a condition affecting about 10% of women globally. The project focuses on developing a novel therapeutic called ENDO-205, which targets specific pathways involved in the disease's progression. Unlike current treatments that often have undesirable side effects and do not address the root cause, ENDO-205 is designed to be absorbed only by endometriosis tissue, potentially offering a more effective solution. The research is part of a broader initiative to improve women's health and is recognized as a high priority by the NICHD.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with endometriosis who are seeking alternative treatment options beyond hormonal therapies.
Not a fit: Patients who do not have endometriosis or those who have already undergone definitive surgical treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a much-needed curative option for women suffering from endometriosis, significantly improving their quality of life.
How similar studies have performed: While there have been various approaches to treating endometriosis, the specific non-hormonal therapeutic strategy being developed in this research is novel and has not been extensively tested in prior studies.
Where this research is happening
Irvine, UNITED STATES
- Endomet Biosciences, INC — Irvine, United States (Active)
Researchers
- Principal investigator: Petrossian, Tanya Christineh — Endomet Biosciences, INC
- Study coordinator: Petrossian, Tanya Christineh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.